Carlberg et al., “Vitamin D-Retinoid Association: Molecular Basis and Clinical Applications”, J. Invest. Dermatol. Symp. Proc., 1(1), 82-86, 1996. |
R. Ceovic et al., “Calciprotiol—A Vitamin D3 Analogue (MC 903) in the Treatment of Psoriasis Vulgaris: A Review”, Acta Dermatovenerologica Alpina, Panonica et Adriatica, 7/2, 67-77, 1998 (abstract). |
S. Segaert et al., “Retinoic Acid Modulates the Anti-Prliferation Effect of 1,25-dihydroxyvitamain D3 in Cultured Human Epidermal keratinocytes,” J. Invest. Dermatol., 109/1, 46-54, 1997. |
M. Skopinska et al., “Calcitriol and Isotretinoin Combined Therapy for Precancerous and Cancerous Skin Lesions,” J. Dermatol. Treatment, 8/1, 5-10, 1997. |
A. Bargagna et al., “TLC, HPTLC and HPLC Determination of Cis- and Trans-retinoic Acids, Retiniol and Retinyl Acetate in Topically Applied Products,” Acta. Tachnol. Legis Med., 2(2), 75-86, 1991. |
Van Der Vleuten et al., “In-Patient Treatment with Calcipotriol Versus Dithranol in Refractory Psoriasis”, Eur. J. Dermatol., 5(8), 676-679, 1995 (abstract). |